Relmada Therapeutics
RLMD
RLMD
97 hedge funds and large institutions have $467M invested in Relmada Therapeutics in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
60.91% more ownership
Funds ownership: 57.4% → 118.31% (+61%)
13% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 24
11% more funds holding
Funds holding: 87 → 97 (+10)
Holders
97
Holding in Top 10
3
Calls
$4.18M
Puts
$1.59M
Top Buyers
| 1 | +$45.1M | |
| 2 | +$37.1M | |
| 3 | +$19.9M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
+$19.9M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$16.5M |
Top Sellers
| 1 | -$6.37M | |
| 2 | -$2.62M | |
| 3 | -$2.34M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.85M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.31M |